Last reviewed · How we verify

Butyn (BUTACAINE)

FDA-approved active Small molecule Quality 23/100

At a glance

Generic nameBUTACAINE
Drug classbutacaine
TargetSodium channel alpha subunits; brain (Types I, II, III)
ModalitySmall molecule
Therapeutic areaNeuroscience
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: